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Background: Despite the growing number of studies reporting therapeutic success in water
environments, research involving aquatic exercise among patients with Chronic Obstructive
Pulmonary Disease (COPD) is scarce. This study evaluates the impact of low-intensity water
and floor exercises on COPD.
Methods: Forty two individuals with moderate to very severe COPD, divided into 3 groups:
Control Group (CG), Floor Group (FG) and the Aquatic Group (AG). All participants were as-
sessed using spirometry, respiratory muscle strength (MIP and MEP), the 6-Minute Walk Test
(6MWT), Medical Research Council (MRC), BODE index and the St George’s Respiratory Ques-
tionnaire (SGRQ).
Results: A difference was recorded after intervention for the 6MWT in the AG (p Z 0.02); for
VEF1 in the FG (pZ 0.00) and AG (pZ 0.01); for MIP in the FG (pZ 0.01) and AG (pZ 0.02);
for MEP in the FG (p Z 0.02) and AG (p Z 0.01); the MRC fell in the AG (p Z 0.00). The FG
showed improved quality of life evidenced by the total score on the SGRQ (p Z 0.00). The
BODE index decreased in the FG (p Z 0.00) and AG (p Z 0.01).
Conclusion: Results show that both forms of low-intensity physical exercise benefit patients
with moderate and very severe COPD. The AG exhibited additional benefits in physical ability,
indicating a new therapeutic modality targeting patients with COPD.
Trial registration number: Australian New Zealand Clinical Trials Registry number 308168.
ª 2012 Elsevier Ltd. All rights reserved.3342 2022; fax: þ55 84 3342 2002.
(G.M.H. Ferreira).
2 Elsevier Ltd. All rights reserved.
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1536 Z.T. de Souto Araujo et al.Introduction The investigationwas approved by the institutional ethicsChronic Obstructive Pulmonary Disease (COPD) is currently
one of the leading causes of morbidity and mortality
worldwide.1 Sufferers develop progressive incapacity and
impaired quality of life associated with healthcare costs,
including hospitalization for complications.2 Intolerance of
physical exertion among these patients is one of the main
consequences of the disease, primarily due to decreased
ventilatory capacity.3,4 The disease has been associated
with dyspnea and reduced quality of life,5 leading to
significant functional limitations in COPD patients,6
compromising performance in activities of daily living.7
Although this dysfunction has multifactorial causes,
chronic decline in fitness is a major factor in the patho-
genesis of muscle abnormalities. As such, several treatment
strategies have been proposed, including physical exer-
cise,8 considered the best available form of improving
muscle function.6,7
Physical training can also optimize motivation to exer-
cise, reduce mood changes,9 lessen symptoms,10 and
improve cardiovascular function. Thus, given the benefits
of physical exercise for individuals with COPD, their
participation in these activities is essential.
Research on aquatic exercise for COPD patients is
scarce. As a result, the present study sought to determine
the impact of a water environment on the effectiveness of
training by comparing the effect of aquatic and floor
exercises on the treatment of these patients.
Methods
Patients
This randomized clinical trial assessed 42 individuals with
a clinical and functional diagnosis of moderate to very
severe COPD,11 submitted to physical exercise protocol.
Patients were allocated into 3 experimental groups: Control
Group (CG), Floor Group (FG) and Aquatic Group (AG).
Subjects were over 40 years of age, from both sexes,
who gave informed written consent; were clinically stable
without periods of exacerbation for at least 8 weeks; non-
smokers or ex-smokers for at least 3 months; were free of
lung infection and had medical supervision and authoriza-
tion for inclusion in the study.
Individuals excluded were those presenting with exacer-
bation of thediseaseduring the studyperiod, preventing them
from participating in three consecutive sessions; neuromus-
cular, renal and cardiac disease; patients with uncontrolled
hypertension and diabetes mellitus; and those who did not
perform functional tests or did not complete the 24 sessions.
Pharmacological therapy was optimized before the
enrollment in the study for all the patients. However, it was
administered according to the hours of individualized
prescription based on the stage of COPD and the subject’s
individual response to drug therapy. Furthermore, the
pharmacological therapy was administered simultaneously
with physical training, based on the level of disease
severity and clinical symptoms. The following drugs were
used: bronchodilators, anticholinergics, methylxanthines
and corticosteroids.committee and registered in the Australian New Zealand
Clinical Trials Registry (ANZCTR) under the number 308168.
Anthropometric evaluation
The body weight was measured in kilograms (kg), height in
meters (m) and Body Mass Index (BMI) with the formula
weight/height2 (kg/m2).
Pulmonary function evaluation
Forced Vital Capacity (FVC), Forced Expiratory Volume in
one second (FEV1), and the Tiffenau index (FEV1/FVC) were
measured according to recommendations of the American
Thoracic Society (ATS).12,13 Relative values were calculated
using Knudson et al. reference equations.14
Respiratory muscle strength assessment
Maximal Inspiratory (MIP) and Expiratory (MEP) Pressures
were measured according to standards proposed by Black
and Hyatt.15 Three reproducible maneuvers were per-
formed, with values between them differing by no more
than 10% of the highest value.
Functional capacity evaluation
Functional capacity was assessed by maximum distance
traveled in the 6-Minute Walk Test (6MWT), in accordance
with ATS recommendations.16 The test was conducted in
a straight, covered corridor 30 m long. Pulse Oxygen Satu-
ration (SaO2%), Cardiac Frequency (CF), Arterial Pressure
(AP), perceived respiratory exertion scale (Borg dyspnea)
and lower limb fatigue (Borg lower limbs) using the Borg
CR10 scale,17 were measured at the beginning and end of
the testing. Two tests were conducted on alternate days
and the best values were used. The 6MWT was performed
by the same investigator, without assistance, using stan-
dard phrases of encouragement at the end of each minute.
BODE mortality predictor index
The BODE index was calculated for each patient using the
variables FEV1, distance traveled in the 6MWT, MRC and
BMI. Points for each variable were added to determine the
BODE score.
Assessment of health-related quality of life
Health-Related Quality of Life (HRQOL) was assessed using
the St George’s Hospital Respiratory Disease Questionnaire
(SGRQ) modified for three months.18 The survey was
applied in interview format.
Physical exercise program
The incremental test was applied to determine the training
load for upper limbs during the exercise program. This
consisted of lifting weight in a diagonal movement with the
Aquatic exercise on COPD 1537dominant limb for 2 min, alternating with a rest period of
equal length, and progressively increasing weight (0.5 kg)
until patients reached their limit. Limits were established
when subjects were incapable of coordinated movement or
reported they were physically unable to finish the sequence
initiated within the time set. FC, SaO2 and the Borg scale
were determined before and after testing.19
The exercise program proposed was composed of
dynamic and isotonic exercises designed for different
muscle groups in the upper and lower limbs.
Training sessions were conducted three times a week
over eight weeks, totaling 24 sessions. Each session lasted
1 h and 30 min, including rest periods and training sessions
were divided into four stages.19,20
Floor exercise program
1st stage: continuous exercises for upper and lower
limbs, for 15 min, without weights according to the
ability of each patient, consisting of callisthenic activi-
ties associated with the respiratory cycle;
2nd stage: unsupported upper limb exercises using
weights (halters) and diagonal movements for 2 min,
with equal rest periods. Weekly loads were increased
according to the individual ability of each participant.
Ideal weight used was previously established by the
incremental test, training with an initial weight of 50% of
the maximum load supported by the subject;
3rd stage: lower limb training performed on an exercise
bicycle for 30 min. Exercise intensity was determined indi-
vidually by aBorg dyspnea andperceived effort score of 5.20
4th stage: 15 min of cooling-down exercises for muscle
groups used during the session.
Aquatic exercise program
The physical training session was divided into four phases,19
in a pool heated to 32  2 C:
1st phase: continuous warm-up exercises for the upper
and lower limbs for 15 min, without weights, consisting
of callisthenic activities related to the respiratory cycle.
2nd phase: unsupported upper limb exercises, using two
diagonal movements and weights (halters) for 2 min, with
an equal rest period. Loads were increased weekly in
accordance with the ability of each subject. Ideal weight
was previously established for each individual using the
incremental test and training with an initial weight of 50%
of the maximum load supported by the patient.
3rd phase: training for lower limbs using floats posi-
tioned between the legs and subjects performing bicycle
movements in the water for 30 min. Exercise intensity
was individually determined by applying the BORG
dyspnea and perceived effort score of 5.20
4th phase: approximately 15 min of cooling down exer-
cises for muscle groups used during the session.
Data analysis
Data were processed with the SPSS version 16.0 (SPSS Inc.
Chicago, IL, USA), applying a significance level of 5%. The
KolmogoroveSmirnov test was used to determine datanormality. With regard to statistical inference, the
Student’s t-test was applied for paired samples in order to
separately analyze pre- and post-intervention data for each
group. ANOVA test was applied for variables evaluating
pulmonary function, respiratory muscle strength, physical
ability, dyspnea assessment, the BODE index and the
quality of life questionnaire. These were assessed before
and after treatment, calculating pre- and post-intervention
differences for all groups. In the case of intergroup differ-
ences, the Tukey test was applied.Results
Initially, 42 individuals were evaluated, with ages ranging
from 45 to 80 years, diagnosed with clinical and functional
COPD. However, 10 patients were excluded (Fig. 1). Thus,
32 patients were randomly assigned to 3 groups: 11 in the
control group (CG); 13 the floor group (FG) and 8 aquatic
group (AG). Groups were similar at baseline, with the
exception of age, in which CG group was older than the
other two groups (Table 1).
In relation to pulmonary function, both training groups
significantly improved FEV1 post-intervention (FG,
42.92  14.11 vs 49.46  11.67% and AG, 43.88  10.27 vs
48.25  12.59%), while the CG exhibited a significant
decrease in the FEV1/FVC (64.27  7.05 vs 60.18  6.70%)
ratio on reassessment (Fig. 2). However, no significant
difference was observed among the three groups after
training (FEV1, p Z 0.41; FVC, p Z 0.43; FEV1/FVC,
p Z 0.05).
When evaluating respiratorymuscle strength, a statistical
difference was observed in maximal respiratory pressures in
the training groups after the physical exercise program; MIP
in the FG (71.92  30.10 vs 104.23  29.57 cmH2O) and AG
(91.25 36.03 vs 123.75 54.49 cmH2O) and MEP for the FG
(86.15  37.14 vs 112.69  41.86 cmH2O) and AG
(79.38  30.52 vs 96.25  32.48 cmH2O). No significant
difference was recorded in the CG post-intervention.
However, intergroup comparison showed a significant
difference in the MIP between the CG and training groups
post-intervention (Fig. 3).
The parameters evaluated during the 6MWT are shown in
Table 2. There was no difference between groups for 6MWD
or for mean for dyspnea at rest and after the 6MWT. Only
the FG showed a significant reduction in Rate of Perceived
Exertion (RPE).
After training, the dyspnea index was significantly lower
in the AG (2.63  0.91 vs 1.88  0.83), and higher in the CG
(1.91  1.04 vs 2.55  0.68). Intergroup comparison
revealed a difference between the CG and FG following
intervention (Fig. 4A).
In regard to risk of death from COPD, we found a signif-
icant reduction in the BODE index for the physical training
groups: SG (3.15  1.72 vs 2.62  1.71) and AG (3.62  1.30
vs 2.62  1.50), whereas this index increased in the CG
(3.64  2.11 vs 4.82  1.94). A post-intervention variation
was recorded between the CG and FG, and between the CG
and AG (Fig. 4B).
Overall pre-intervention SGRQ scores in the CG, FG and
AG were 62.0%, 49.5% and 48.0%, respectively. There was no
significant difference between groups at the beginning of the
Figure 1 Flowchart of participant in this study.
1538 Z.T. de Souto Araujo et al.study (pZ 0.37). TheCGdisplayed a significant rise in impact
domains and total score. A significant decreasewas recorded
for all domains in the FG. The AG exhibited a slight reduction
(>4 points) in all domains, though not significant. Intergroup
comparison indicated a significant difference in the CG and
FG for all domains of the SGRQ (Fig. 5).Discussion
The present study assessed the impact of two low-intensity
physical training protocols (floor and aquatic exercise) onTable 1 Baseline characteristics of the sample studied.
Characteristics GC (n Z 11) FG (n
Gender (F/M) 3/8 5/8
Age (yr) 71.1  10.1 56.9
Height (m) 1.63  0.12 1.58
Weight (kg) 64.6  14.7 74.4
BMI (kg/m2) 24.4  6.7 30.0
MRC 1.91  1.04 1.77
FEV1 (% pred) 45.1  12.6 39.2
6MWD (m) 393.3  135.1 446.5
BODE index 3.64  2.11 3.15
MIP (cmH2O) 59.6  27.1 71.9
MEP (cmH2O) 85.0  28.0 86.2
BMI: body mass index; MRC: Medical Research Council; FEV1: force
distance; MIP: maximal inspiratory pressure; MEP: maximal expiratory
ns: no significant.COPD, by analyzing several outcomes. The data suggest
that both modalities of low-intensity physical exercise were
beneficial to patients with moderate to very severe COPD.
An interesting finding is that, with the same exercise
intensity, the group submitted to training in water exhibi-
ted additional benefits for physical capacity in relation to
the floor exercise group.
COPD occurs among adults, primarily from their forties
onwards. This may explain the difference between the CG
and FG in regard to age, despite the randomized nature of
the study. However, for the lungs in particular, it is difficult
to distinguish between impacts resulting solely fromZ 13) AG (n Z 8) p-value
4/4 e
 7.9 62.4  9.9 0.03
 0.10 1.57  0.12 ns
 22.3 68.9  13.8 ns
 10.1 28.2  8.0 ns
 1.23 2.63  0.91 ns
 11.4 43.9  10.3 ns
 114.5 434.6  120.9 ns
 1.72 3.63  1.30 ns
 30.1 91.3  36.0 ns
 37.1 79.4  30.5 ns
d expiratory volume in one second; 6MWD: six-minute walking
pressure; CG: control group; FG: floor group; AG: aquatic group;
Figure 2 Lung function pre- and post-intervention. FEV1_pre:
forced expiratory volume in one second pre; FEV1_post: forced
expiratory volume in one second post; FVC_pre: forced vital
capacitypre; FVC_post: forced vital capacitypost; FEV1/FVC_pre:
Tiffenau index pre; FEV1/FVC_post: Tiffenau index post.
*p < 0.05.
Aquatic exercise on COPD 1539physiological aging and those attributed to the cumulative
effect of environmental action.
Thus, cellular changes caused by aging and those
provoked by smoking may involve interrelated pathogenic
mechanisms. Aging can lower the injury threshold or
increase mechanisms involved in lung damage through
smoking. Tobacco smoke can also act as an environmental
factor, disrupting organ repair and maintenance, contrib-
uting to the aging process.21
According to our results, FEV1 increased significantly in
the training groups. This finding corroborates several
literature studies1,5 confirming that the rehabilitation
program results in improved spirometry, despite previous
research indicating pulmonary rehabilitation does not alter
pulmonary function.19,22 Nevertheless, the long-term
behavior of pulmonary function after completing a phys-
ical exercise program is unknown.Patients who presented exacerbation and therefore
changed the medication were excluded. The individuals
used the same drug and dose during the entire study. Thus,
the changes in FEV1 in the training groups were induced by
exercise.
This outcome in pulmonary function among trained
individuals is due to improved oxidative capacity, resulting
in efficient skeletal muscles that reduce alveolar ventila-
tion for a given work rate, thereby decreasing the dynamic
hyperinflation found in COPD patients.
Several studies23,24 have shown that physical training or
respiratory reeducation may increase respiratory muscle
strength, although the effectiveness of specific muscle
training is widely debated.9 In the present study, which
used low-intensity physical exercise without specific
respiratory muscle training, MIP and MEP increased signifi-
cantly with the intervention proposed and was better in
training groups when compared to the control. However,
there was no difference in regard to the environment used
and maximal respiratory pressures.
A possible explanation for the respiratory muscle
strength gain achieved through physical exercise is struc-
tural changes in the size and proportion of type I and II
muscle fibers of the internal and external intercostal
muscles, as well as accessory respiratory muscles.25
In clinical practice, the 6MWT is frequently used to
evaluate changes in functional capacity among COPD
patients after pulmonary rehabilitation.23 Contrary to
expectations, physical training groups in this study did not
significantly increase 6MWT distance following intervention
when compared individually to the CG.
A number of clinical investigations have analyzed the
benefits of pulmonary rehabilitation through exercise
capacity, severity of dyspnea and HRQOL. These findings
are based on controlled, randomized clinical trials. Results
obtained for these three variables show that benefits to
COPD are generally greater than in any other treatment.9
A significant increase was also observed in the 6MWT
following intervention for the AG, in accordance with the
relevant literature.9,20,26 This important outcome is
directly reflected in the improved functional capacity
recorded in the group submitted to water training, since
aerobic metabolism is the energy source used to sustain
physical activity in water.
Redelmeier et al.27 studied 112 patients with COPD,
suggesting that an alteration of 54 m in the 6MWT can be
considered clinically relevant. Puhan et al.28 reported that
6MWT must change by approximately 35 m in subjects with
moderate to severe COPD in order to represent a significant
effect.
This was not observed in the floor exercise group, which
exhibited a slight increase of only 22 m after training.
Furthermore, a reduction in the 6MWT was recorded in the
CG, corroborating a similar study.20 This demonstrates the
high physical and functional limitations of physically inac-
tive COPD patients.
Thus, these results indicate that energy spent perform-
ing aquatic exercises is greater when compared with floor
exercises, capable of achieving double the value required
to produce an aerobic training effect in this environment.
The assessment of HRQOL is an important issue to take
into account when developing therapeutic strategies and
Figure 3 Respiratory muscle strength pre- and post-inter-
vention. MIP_pre: maximal inspiratory pressure pre; MEP_post:
maximal inspiratory pressure post; MEP_pre: maximal expira-
tory pressure pre; MEP_post: maximal expiratory pressure
post. *p < 0.05.
1540 Z.T. de Souto Araujo et al.evaluating the results thereof. At the beginning of the
present study, the SGRQ was not able to differentiate the
three groups, but for all domains analyzed the GC showed
the worst quality of live. Perhaps this can be explained by
the GC have more elderly patients than the other groups
examined, and probably have a reduced ability to perform
activities with age.29Table 2 Six-minute walking test parameters of CG and training
CG FG
6MWD (m) Pre 393.3  135.1 44
Post 360.7  129.4 46
Intragroup p Z 0.02 ns
Rest dyspnea Pre 1.28  1.31 1.
Post 0.90  0.70 0.
Intragroup p Z 0.00 p
Final dyspnea Pre 4.59  2.53 3.
Post 5.04  2.26 3.
Intragroup p Z 0.00 p
Rest leg discomfort Pre 0.18  0.40 0.
Post 0.36  0.50 0.
Intragroup ns ns
Final leg discomfort Pre 4.36  1.12 3.
Post 4.09  1.81 2.
Intragroup ns p
a Control group and aquatic group e pre.
b Floor group and aquatic group e pre.
c Floor group and aquatic group e post.It is well documented that individuals with COPD have
impaired HRQOL.9,20 When assessing quality of life levels
among patients in the present study, a difference was
found in all domains of the COPD-specific questionnaire,
the SGRQ, before and after physical training. Research on
the effects of pulmonary rehabilitation in COPD patients
found better scores for all domains of the SGRQ after
rehabilitation.22,30
This study recorded an important clinical difference in
the aquatic training group for all SGRQ domains. This
alteration, evidenced by the increase greater or equal to 4%
in any domain or the sum of all points, after intervention,
represents a significant change in quality of life for subjects
with COPD.18
The CG displayed a significant post-intervention increase
in the impact domain and total score, as well as a clinical
rise in symptom and activity scores. These findings reveal
an important clinical reduction in HRQOL for physical
training groups. A significant difference was found between
the CG and FG for all domains.
Results show that physical exercise lessened the severity
and frequency of COPD symptoms, increasing physical
performance for a certain level of activity, in addition to
optimizing social and psychological function among these
individuals.
Dyspnea as a limiting factor during physical activity is
a common complaint in COPD sufferers with moderate to
severe obstruction. The present study recorded lower
dyspnea in physical training groups, corroborating previous
investigations.31,32 This reduction can be explained by
decreased ventilation levels during submaximal exercise
resulting from training, promoting improvements in the
aerobic capacity of skeletal muscles. This lowers blood
lactate concentration and increases mechanical efficiency
in these muscles.33
This study observed a decrease in the BODE index after
physical exercise for both groups, in accordance with the
relevant literature,34e36 confirming that physical activity asgroups pre- and post-intervention.
AG Intergroup comparison
6.5  114.5 434.6  121.0 ns
8.8  106.8 490.9  137.8
p Z 0.02
44  1.19 1.22  1.27 ns
65  0.71 1.12  1.09
Z 0.00 p Z 0.01
42  1.63 5.00  3.62 ns
17  2.03 3.25  1.16
Z 0.00 p Z 0.01
11  0.29 1.28  1.12 p Z 0.00a
23  0.83 1.12  0.99 p Z 0.00b
ns p Z 0.04c
84  1.51 4.81  3.60 ns
57  1.80 3.18  1.77
Z 0.00 ns
Figure 4 A, Dyspnea pre- and post-intervention. B, BODE index pre- and post-intervention. *p < 0.05.
Aquatic exercise on COPD 1541a pulmonary rehabilitation program can reduce dyspnea
levels among individuals with COPD.
In our study, the GC experienced a worsening of most of
the recorded variables considered at the end of 8 weeks
treatment period. The difficulties imposed by COPD, dysp-
nea, functional limitation and physical inactivity may have
contributed significantly to these findings. It is known that
the reduced fitness triggers restrictions in activities of daily
living of these patients, isolating them from social and
harming their personal and family relations.37 Therefore,
these patients benefit from exercise training programs,
improving exercise tolerance, symptoms of dyspnea and
fatigue.
Studies of the aquatic environment in COPD patients
are scarce. We found only two investigations in the
existing literature comparing aquatic and floor exerciseFigure 5 Domains of the St George’s Respiratory Questionnenvironments in this population.20,38 The first carried out
reports that all subjects performed exercises better in
water, with no clinically relevant desaturation, arrhythmia
or discomfort and suggest that cardiorespiratory adaptation
during physical training in water fully compensates the
restricted lung volume evidenced by hydrostatic pressure.38
The second study, using high-intensity exercise, concluded
that the water training group showed additional benefits in
physical capacity and physical health in relation to the floor
exercise group.20 Our results show that low-intensity
physical exercise protocols produce similar responses.
In the present study, ten patients were dropped, and six
of them belonging to the AG group. These dropouts may be
justified by motivational issues since it is an extensive
program. Furthermore we should consider the preferences
of patients, because the pool provides an exposure of theaire pre- and post-intervention. *p < 0.05; **p < 0.001.
1542 Z.T. de Souto Araujo et al.body bigger than the floor. Thus, the selection of highly
motivated participants is especially important in the case
of programs in an outpatient regimen.39 We also cannot
discard the possibility of abandoning the treatment for
financial reasons to afford the displacement till the place of
rehabilitation.
In conclusion both programs water and floor exercises
produced positive results, with water environments having
the added advantage of being low impact, in addition to
representing a new therapeutic modality for COPD
sufferers.Conflict of interest
None declared.References
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